NEWARK, N.J. - A New Jersey federal judge on May 31 denied a motion by a Boston Scientific Corp. subsidiary to dismiss a False Claims Act complaint by two former employees that the subsidiary manipulated billing codes to get federal health care programs to pay for spinal cord stimulators (United States of America ex rel. Wendy Bahnsen, et al. v. Boston Scientific Neuromodulation Corp., No. 2:11-1210, D. N.J.; 2013 U.S. Dist. LEXIS 76612).